AC IMMUNE SA SF-02 (IMR) — Financial Flexibility Index
AC IMMUNE SA SF-02 (IMR) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of €-16.40 Million (operating CF €-16.51 Million minus capex €107.00K) represents 0% of total liabilities (€109.37 Million). Also explore IMR shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AC IMMUNE SA SF-02 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for AC IMMUNE SA SF-02 across 5 annual periods. Check IMR capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for AC IMMUNE SA SF-02 (2021–2025)
Year-by-year free cash flow to debt coverage for AC IMMUNE SA SF-02. For the full company profile including market capitalisation, see IMR market cap.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.63x | €-68.36 Million | €-69.26 Million | €109.37 Million | ▼ -211.7% |
| 2024 | 0.56x | €66.42 Million | €65.84 Million | €118.64 Million | ▲ +120.8% |
| 2023 | -2.69x | €-59.61 Million | €-60.41 Million | €22.17 Million | ▲ +37.0% |
| 2022 | -4.27x | €-72.33 Million | €-73.57 Million | €16.95 Million | ▼ -99.4% |
| 2021 | -2.14x | €-63.05 Million | €-65.69 Million | €29.46 Million | — |